Salveen Richter
Stock Analyst at Goldman Sachs
(3.52)
# 751
Out of 5,182 analysts
213
Total ratings
43.1%
Success rate
7.57%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Neutral | $9 → $10 | $17.54 | -42.99% | 11 | Apr 20, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $28 → $32 | $25.74 | +24.32% | 11 | Apr 1, 2026 | |
| DNLI Denali Therapeutics | Maintains: Buy | $35 → $40 | $19.44 | +105.76% | 6 | Mar 26, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgrades: Neutral | $61 → $25 | $24.28 | +2.97% | 4 | Mar 24, 2026 | |
| GENB Generate Biomedicines | Initiates: Buy | $26 | $12.86 | +102.18% | 1 | Mar 24, 2026 | |
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $52.85 | -22.42% | 11 | Feb 17, 2026 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.47 | -23.95% | 3 | Nov 5, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $25.13 | -36.33% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $74.12 | -12.30% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $40.94 | -56.03% | 9 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $23.01 | +12.99% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $504 → $566 | $313.79 | +80.38% | 6 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $38 | $9.63 | +294.81% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $20.42 | -6.95% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $22.13 | -23.18% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $43.89 | -15.70% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $55.18 | -14.82% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $53.98 | +92.66% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $22.27 | +84.10% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $13.82 | -27.64% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $766.02 | +4.96% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $187.88 | +4.85% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $15.08 | +19.40% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $133.64 | -28.17% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $15.87 | -24.39% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $229.14 | -68.58% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $95.47 | -26.68% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $348.62 | +0.40% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $435.10 | +28.48% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $39.44 | -87.32% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.35 | +1,219.15% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $231.98 | -3.01% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.84 | +472.92% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.67 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $7.31 | +310.40% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.50 | +157.14% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $6.40 | -53.13% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.44 | +74.42% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $92.19 | -53.36% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.92 | -48.98% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $4.89 | +1,944.15% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $5.90 | +10,069.49% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $127.05 | -60.65% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $74.40 | -39.52% | 1 | Mar 17, 2020 |
uniQure
Apr 20, 2026
Maintains: Neutral
Price Target: $9 → $10
Current: $17.54
Upside: -42.99%
Agios Pharmaceuticals
Apr 1, 2026
Maintains: Neutral
Price Target: $28 → $32
Current: $25.74
Upside: +24.32%
Denali Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $19.44
Upside: +105.76%
Ultragenyx Pharmaceutical
Mar 24, 2026
Downgrades: Neutral
Price Target: $61 → $25
Current: $24.28
Upside: +2.97%
Generate Biomedicines
Mar 24, 2026
Initiates: Buy
Price Target: $26
Current: $12.86
Upside: +102.18%
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $52.85
Upside: -22.42%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.47
Upside: -23.95%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $25.13
Upside: -36.33%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $74.12
Upside: -12.30%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $40.94
Upside: -56.03%
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $23.01
Upside: +12.99%
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $313.79
Upside: +80.38%
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.63
Upside: +294.81%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $20.42
Upside: -6.95%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $22.13
Upside: -23.18%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $43.89
Upside: -15.70%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $55.18
Upside: -14.82%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $53.98
Upside: +92.66%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $22.27
Upside: +84.10%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.82
Upside: -27.64%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $766.02
Upside: +4.96%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $187.88
Upside: +4.85%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $15.08
Upside: +19.40%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $133.64
Upside: -28.17%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $15.87
Upside: -24.39%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $229.14
Upside: -68.58%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $95.47
Upside: -26.68%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $348.62
Upside: +0.40%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $435.10
Upside: +28.48%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $39.44
Upside: -87.32%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.35
Upside: +1,219.15%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $231.98
Upside: -3.01%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.84
Upside: +472.92%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $23.67
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $7.31
Upside: +310.40%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.50
Upside: +157.14%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $6.40
Upside: -53.13%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.44
Upside: +74.42%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $92.19
Upside: -53.36%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.92
Upside: -48.98%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $4.89
Upside: +1,944.15%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $5.90
Upside: +10,069.49%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $127.05
Upside: -60.65%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $74.40
Upside: -39.52%